Global Health |
||||
|
|
Diarrheal Disease Advocacy: Findings from a Scan of the Global Funding and Policy LandscapeLaura Herman, Leigh Fiske, Jennifer Splansky This document summarizes the findings of an external scan commissioned by PATH, a global health nonprofit organization, to help in form their advocacy strategy around diarrheal disease, the world’s second leading killer of children. Smarter Programming of the Female Condom: Increasing Its Impact on HIV Prevention in the Developing WorldKyle Peterson, Laura Herman, Leigh Fiske, Elliot Marseille, James G. Kahn This FSG research report examines how the female condom fits within the landscape of HIV prevention tools currently available, and makes recommendations for increased cost-effectiveness and impact. A New Approach to Product Development Partnership Performance MeasurementKyle Peterson, Marc Pfitzer, Laura Herman, Patty Russell, David Zapol, Mike Stamp FSG examines the current and potential state of performance measurement for Product Development Partnerships (PDPs), offering a comprehensive and customizable framework to assist PDPs and donors in deciding how to measure progress. Beyond R&D: Leveraging the Pharmaceutical Industry on Issues of Drug AccessKyle Peterson, Fay Hanleybrown, Laura Herman This FSG study, based on case studies in India and Kenya, finds that pharmaceutical companies are under-utilizing their post-R&D assets and capabilities. Social Investment Trends in the Pharmaceutical Industry: A Review of Global Pharmaceutical FirmsKyle Peterson, Laura Herman FSG provides the first comprehensive review of the business and social impacts that pharmaceutical companies generate through their philanthropic investments. |
|||